Reduction of Particle Size of Drug Substance for Low‐Dose Drug Products

This chapter contains sections titled: Introduction Reduction of Particle Size of Drug Substance by Milling Technologies Reduction of Particle Size of Drug Substance Using Crystallization Technologies Scale‐Up Considerations Emerging Technologies and Future Directions Acknowledgments References

Saved in:
Bibliographic Details
Published inFormulation and Analytical Development for Low‐Dose Oral Drug Products pp. 205 - 222
Main Authors Burcham, Christopher L, Collins, Paul C, Jarmer, Daniel J, Seibert, Kevin D
Format Book Chapter
LanguageEnglish
Published Hoboken, NJ, USA John Wiley & Sons, Inc 22.01.2009
Subjects
reduction of particle size of drug substance for low‐dose drug products
reduction of particle size of drug substance using crystallization technologies
Supercritical fluid crystallization (SFC)
Online AccessGet full text

Cover

Abstract This chapter contains sections titled: Introduction Reduction of Particle Size of Drug Substance by Milling Technologies Reduction of Particle Size of Drug Substance Using Crystallization Technologies Scale‐Up Considerations Emerging Technologies and Future Directions Acknowledgments References
AbstractList This chapter contains sections titled: Introduction Reduction of Particle Size of Drug Substance by Milling Technologies Reduction of Particle Size of Drug Substance Using Crystallization Technologies Scale‐Up Considerations Emerging Technologies and Future Directions Acknowledgments References
Author Jarmer, Daniel J
Seibert, Kevin D
Burcham, Christopher L
Collins, Paul C
Author_xml – sequence: 1
  givenname: Christopher L
  surname: Burcham
  fullname: Burcham, Christopher L
  organization: Chemical Product R&D, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, IN 40285, USA
– sequence: 2
  givenname: Paul C
  surname: Collins
  fullname: Collins, Paul C
  organization: Chemical Product R&D, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, IN 40285, USA
– sequence: 3
  givenname: Daniel J
  surname: Jarmer
  fullname: Jarmer, Daniel J
  organization: Chemical Product R&D, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, IN 40285, USA
– sequence: 4
  givenname: Kevin D
  surname: Seibert
  fullname: Seibert, Kevin D
  organization: Chemical Product R&D, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, IN 40285, USA
BookMark eNptUNtKw0AQXVFBW_sBvuUHUme6yV4epdVaKFisPodkM6vRkC3ZhGKf_AS_0S-xMSIUHBiGc-ac83AG7KRyFTF2iTBGgMmVlgoiCVwJLnBsXtQRG_wR_LgHEAvQ4oyNvH-F_WAsOYhztnigvDVN4arA2WCV1k1hSgrWxY46Yla3z8G6zXyTVoYC6-pg6bZfH58z56n_rmrXJfgLdmrT0tPo9w7Z0-3N4_QuXN7PF9PrZegxBhsqKbXRhCQUj1WMkZBAIlNoAdJM5lyBsUiR0BmQRm1EGlll0FI-SWMEPmTY526Lkt4Typx78wlC0pWRHJSR7Mvodu8J__EcanfF5ke_yS3_BkzpY24
ContentType Book Chapter
Copyright Copyright © 2009 John Wiley & Sons, Inc.
Copyright_xml – notice: Copyright © 2009 John Wiley & Sons, Inc.
DOI 10.1002/9780470386361.ch8
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISBN 0470386363
9780470386361
Editor Zheng, Jack
Editor_xml – sequence: 1
  givenname: Jack
  surname: Zheng
  fullname: Zheng, Jack
  organization: Pharmaceutical Sciences R&D, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 40285, USA
EndPage 222
ExternalDocumentID 10.1002/9780470386361.ch8
Genre chapter
GroupedDBID 089
20A
38.
3VX
3X9
3XM
4ST
5KU
5VX
A4I
A4J
AABBV
AAFHC
AAKRR
AARDG
ABARN
ABISH
ABQPQ
ABQPW
ACIQC
ACLGV
ACMHW
ACYFF
ADVEM
AERYV
AESZG
AHUFE
AJFER
ALMA_UNASSIGNED_HOLDINGS
ALTAS
AZZ
BBABE
BPBUR
CBNEP
CWLBG
CZZ
DNKAV
HF4
HZKEI
IFKZM
IPJKO
IVK
IWC
IWL
J-X
JFSCD
JJU
KIGQS
LMJTD
MYL
NK1
NK2
NL5
PLCCB
PQEST
PQQKQ
PQUKI
UQ7
W1A
YPLAZ
YSPEL
ZEEST
ID FETCH-LOGICAL-s150f-8779c9e1e68358514670e6b81f00ab7d380cf1e469b0e919c6a4f8c1fed2a5103
ISBN 0470056096
9780470056097
IngestDate Wed Nov 27 04:58:33 EST 2019
Thu Jun 02 19:30:52 EDT 2022
IsPeerReviewed false
IsScholarly false
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-s150f-8779c9e1e68358514670e6b81f00ab7d380cf1e469b0e919c6a4f8c1fed2a5103
PageCount 18
ParticipantIDs wiley_ebooks_10_1002_9780470386361_ch8_ch8
PublicationCentury 2000
PublicationDate 2009-01-22
PublicationDateYYYYMMDD 2009-01-22
PublicationDate_xml – month: 01
  year: 2009
  text: 2009-01-22
  day: 22
PublicationDecade 2000
PublicationPlace Hoboken, NJ, USA
PublicationPlace_xml – name: Hoboken, NJ, USA
PublicationTitle Formulation and Analytical Development for Low‐Dose Oral Drug Products
PublicationYear 2009
Publisher John Wiley & Sons, Inc
Publisher_xml – name: John Wiley & Sons, Inc
SSID ssj0000157306
Score 1.3810225
Snippet This chapter contains sections titled: Introduction Reduction of Particle Size of Drug Substance by Milling Technologies Reduction of Particle Size of Drug...
SourceID wiley
SourceType Enrichment Source
Publisher
StartPage 205
SubjectTerms reduction of particle size of drug substance for low‐dose drug products
reduction of particle size of drug substance using crystallization technologies
Supercritical fluid crystallization (SFC)
Title Reduction of Particle Size of Drug Substance for Low‐Dose Drug Products
URI https://onlinelibrary.wiley.com/doi/abs/10.1002/9780470386361.ch8
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JbtswECUc91L00hVNN_BQ-NBEKUVJlHhOUqRB0xqoA-RmUBLZ-FA78JIgPvUT-hX9sH5JZ0hRS20USA8WDIogKD6CMxy-eSTkrSmsaksYgDFXQSx5GSidykCkqc7CRGuuMA559lmcnMenF8lFr_erxVpaLfODYr01r-R_UIUywBWzZO-AbN0oFMB_wBeegDA8_3J-u2FWf6nm9-ruLXsCYOVFXGS6xQSyNMJPs5ua1HCEBPUvmJZ_NF99w0QBVHxtguV4OZSbJC3dgb06RHxoRbwXnlTYBFlP1by6iMVlrbfOm7RV8HVZQNeTqScZV6rgqB3r3dZhNZH3vk7WNphh-4iL29KmNmz9mM3v8FEM5GgFvNnzbqEJdbmgbr_L4hS1S5mj9Po1lyUt881dqxuWwSnNVm1EmYhEeFBcZo0ZrMmJ_6i9Q3ZgPeuTe-AzHJ_VsTxwqWChFFbwoOqg8OJOvsP-RJ3x9xvNdjdG1rMZPSQPMNuFYhoK9O4R6enpYzIYOkHz2306avLzFvt0QIeN1PntE_KxRo_ODPXoUUQPCxAZWqNHAT0K6P3-8RNxc289bk_J-Yfj0eFJUF3OESxgD2HAiqaykDrUAnx4cNvB4DIt8iw0jKk8LaOMFSbUsZA50zKUhVCxyYrQ6JIrlHF8RvrT2VQ_JxTKIh2mBZdFHhuVKFYqpozMtEyimJe75J0dnrHlDyzGTmmbjzvjOIZxxN8uGXQqdyutJ1e24lVpXtyl1ZfkfjNrX5H-cr7Sr8EbXeZvqsnwB2r4gBc
link.rule.ids 779,780,784,793,27925
linkProvider ProQuest Ebooks
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=bookitem&rft.title=Formulation+and+Analytical+Development+for+Low%E2%80%90Dose+Oral+Drug+Products&rft.au=Burcham%2C+Christopher+L&rft.au=Collins%2C+Paul+C&rft.au=Jarmer%2C+Daniel+J&rft.au=Seibert%2C+Kevin+D&rft.atitle=Reduction+of+Particle+Size+of+Drug+Substance+for+Low%E2%80%90Dose+Drug+Products&rft.date=2009-01-22&rft.pub=John+Wiley+%26+Sons%2C+Inc&rft.isbn=9780470056097&rft.spage=205&rft.epage=222&rft_id=info:doi/10.1002%2F9780470386361.ch8&rft.externalDocID=10.1002%2F9780470386361.ch8
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=9780470056097/lc.gif&client=summon&freeimage=true
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=9780470056097/mc.gif&client=summon&freeimage=true
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=9780470056097/sc.gif&client=summon&freeimage=true